Attached files

file filename
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Xenetic Biosciences, Inc.xenetic_10k-ex3101.htm
10-K - FORM 10-K - Xenetic Biosciences, Inc.xenetic_10k-123119.htm
EX-32.1 - CERTIFICATION - Xenetic Biosciences, Inc.xenetic_10k-ex3201.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Xenetic Biosciences, Inc.xenetic_10k-ex3102.htm
EX-23.1 - INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM S CONSENT - Xenetic Biosciences, Inc.xenetic_10k-ex2301.htm
EX-10.53 - STOCK OPTION GRANT NOTICE - Xenetic Biosciences, Inc.xenetic_10k-ex1053.htm
EX-10.52 - STOCK OPTION GRANT NOTICE - Xenetic Biosciences, Inc.xenetic_10k-ex1052.htm
EX-10.51 - FORM OF LETTER AGREEMENT - Xenetic Biosciences, Inc.xenetic_10k-ex1051.htm
EX-10.50 - LETTER AGREEMENT - Xenetic Biosciences, Inc.xenetic_10k-ex1050.htm
EX-4.1 - DESCRIPTION OF REGISTRANTS SECURITIES REGISTERED - Xenetic Biosciences, Inc.xenetic_10k-ex0401.htm

Exhibit 21.1

 

SUBSIDIARIES OF REGISTRANT

 

 

Subsidiary Country / State of Incorporation
   
Xenetic Biosciences (UK), Ltd. United Kingdom registered company
   
Lipoxen Technologies, Ltd. United Kingdom registered company
   
Xenetic Bioscience, Inc. Delaware
   
SymbioTec, GmbH German registered company
   
Hesperix S.A. Swiss registered company